Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry R Davis

Showing results (21-30 of 185) with videos related to

Pageof 19
Sort By:
American Journal of Human Biology : the Official Journal of the Human Biology Council|May 31, 2017
Gender differences and similarities in effects of nonpharmacologic approaches to the treatment of mild hypertensionSylvia Wassertheil-Smoller, Barry R Davis, Albert Oberman, et al.
The American Surgeon|September 28, 2016
Repair of Pectus Excavatum in an Adult: An Example of Disease ProgressionHarold Howe, Gautam Bhatia, Christopher C Wright, et al.
Communications in Statistics: Theory and Methods|March 26, 2019
Conditional moving linear regression: modeling the recruitment process for ALLHATDejian Lai, Qiang Zhang, Jose-Miguel Yamal, et al.
Statistics in Medicine|July 27, 2004
Imputing gene-treatment interactions when the genotype distribution is unknown using case-only and putative placebo analyses--a new method for the Genetics of Hypertension Associated Treatment (GenHAT) studyBarry R Davis, Charles E Ford, Eric Boerwinkle, et al.
International Journal of Hypertension|December 20, 2021
Effects of Posttrial Antihypertensive Drugs on Morbidity and Mortality: Findings from 15-Year Passive Follow-Up after ALLHAT EndedXianglin L Du, Lara M Simpson, Brian C Tandy, et al.
Annals of Internal Medicine|July 9, 2004
ALLHAT: setting the record straightBarry R Davis, Curt D Furberg, Jackson T Wright, et al.
The American Journal of Cardiology|September 7, 2024
Prevention of Heart Failure in Hypertension-the Role of Coronary Heart Disease Events Treated With Versus Without Revascularization: The ALLHAT StudyVincent Chen, Barry R Davis, Samir R Kapadia, et al.
Texas Heart Institute Journal|September 30, 2020
Left Ventricular Noncompaction Detected by Cardiac Magnetic Resonance Screening: A Reexamination of Diagnostic CriteriaAnthony H Masso, Carlo Uribe, James T Willerson, et al.
Frontiers in Cardiovascular Medicine|December 4, 2023
The 18-year risk of cancer, angioedema, insomnia, depression, and erectile dysfunction in association with antihypertensive drugs: post-trial analyses from ALLHAT-Medicare linked dataXianglin L Du, Journey Martinez, Jose-Miguel Yamal, et al.
Plos One|November 18, 2021
Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blockerXianglin L Du, Lara M Simpson, Brian C Tandy, et al.
Pageof 19

Showing results (21-30 of 185) with videos related to

Sort By:
Pageof 19
American Journal of Human Biology : the Official Journal of the Human Biology Council|May 31, 2017
Gender differences and similarities in effects of nonpharmacologic approaches to the treatment of mild hypertensionSylvia Wassertheil-Smoller, Barry R Davis, Albert Oberman, et al.
The American Surgeon|September 28, 2016
Repair of Pectus Excavatum in an Adult: An Example of Disease ProgressionHarold Howe, Gautam Bhatia, Christopher C Wright, et al.
Communications in Statistics: Theory and Methods|March 26, 2019
Conditional moving linear regression: modeling the recruitment process for ALLHATDejian Lai, Qiang Zhang, Jose-Miguel Yamal, et al.
Statistics in Medicine|July 27, 2004
Imputing gene-treatment interactions when the genotype distribution is unknown using case-only and putative placebo analyses--a new method for the Genetics of Hypertension Associated Treatment (GenHAT) studyBarry R Davis, Charles E Ford, Eric Boerwinkle, et al.
International Journal of Hypertension|December 20, 2021
Effects of Posttrial Antihypertensive Drugs on Morbidity and Mortality: Findings from 15-Year Passive Follow-Up after ALLHAT EndedXianglin L Du, Lara M Simpson, Brian C Tandy, et al.
Annals of Internal Medicine|July 9, 2004
ALLHAT: setting the record straightBarry R Davis, Curt D Furberg, Jackson T Wright, et al.
The American Journal of Cardiology|September 7, 2024
Prevention of Heart Failure in Hypertension-the Role of Coronary Heart Disease Events Treated With Versus Without Revascularization: The ALLHAT StudyVincent Chen, Barry R Davis, Samir R Kapadia, et al.
Texas Heart Institute Journal|September 30, 2020
Left Ventricular Noncompaction Detected by Cardiac Magnetic Resonance Screening: A Reexamination of Diagnostic CriteriaAnthony H Masso, Carlo Uribe, James T Willerson, et al.
Frontiers in Cardiovascular Medicine|December 4, 2023
The 18-year risk of cancer, angioedema, insomnia, depression, and erectile dysfunction in association with antihypertensive drugs: post-trial analyses from ALLHAT-Medicare linked dataXianglin L Du, Journey Martinez, Jose-Miguel Yamal, et al.
Plos One|November 18, 2021
Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blockerXianglin L Du, Lara M Simpson, Brian C Tandy, et al.
Pageof 19